Frederick Millard
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
-
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 9
- Prostate Cancer Treatment and Research 9
- Oncology 17
- Co-authors
- P Tani (3 shared papers)Peter Berchtold (3 shared papers)VL Jr Woods (2 shared papers)Robert McMillan (2 shared papers)James M. Randall (8 shared papers)Razelle Kurzrock (1 shared paper)Nicholas J. Vogelzang (2 shared papers)Ithaar Derweesh (7 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Clinical Genitourinary Cancer (5 papers)Cancer (2 papers)Clinical Cancer Research (2 papers)Blood (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Frederick Millard
43 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 68
- Hematology 339
- Pulmonary and Respiratory Medicine 559
- Oncology 334
- Cancer Research 157
- Genetics 97
Countries citing papers authored by Frederick Millard
This map shows the geographic impact of Frederick Millard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Millard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Millard more than expected).
Fields of papers citing papers by Frederick Millard
This network shows the impact of papers produced by Frederick Millard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Millard. The network helps show where Frederick Millard may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick Millard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 247 | |
| 2 | 2001 | 86 | |
| 3 | 2014 | 82 | |
| 4 | Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662. | 2001 | 75 |
| 5 | 2010 | 75 | |
| 6 | 2014 | 68 | |
| 7 | 2006 | 66 | |
| 8 | 2016 | 60 | |
| 9 | 1990 | 55 | |
| 10 | 2017 | 46 | |
| 11 | 2003 | 43 | |
| 12 | 2008 | 39 | |
| 13 | 2007 | 34 | |
| 14 | 2013 | 30 | |
| 15 | 2013 | 29 | |
| 16 | 2013 | 22 | |
| 17 | 2019 | 21 | |
| 18 | 1987 | 19 | |
| 19 | 2011 | 18 | |
| 20 | 2006 | 18 |
About Frederick Millard
Frederick Millard is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Prostate Cancer Treatment and Research (9 papers), Testicular diseases and treatments (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer Genomics and Diagnostics (4 papers), Renal and related cancers (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Hematology (339 citations), Pulmonary and Respiratory Medicine (559 citations), Oncology (334 citations), Cancer Research (157 citations) and Genetics (97 citations). Frederick Millard has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include P Tani, Peter Berchtold, VL Jr Woods, Robert McMillan, James M. Randall, Razelle Kurzrock, Nicholas J. Vogelzang, Ithaar Derweesh, Hedy L. Kindler and Yota Suzuki. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Cancer, Clinical Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.